These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 649965)

  • 1. Haemagglutination assay for HBsAg -- a new approach to reagent preparation.
    Hopkins R; Watt AD; Ross S
    J Immunol Methods; 1978; 20():35-41. PubMed ID: 649965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved economics of HBsAg screening with commercial radioimmunoassay reagents.
    Hopkins R; Ross S; Jordan T; Watt AD
    J Clin Pathol; 1980 Jan; 33(1):19-23. PubMed ID: 6987272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of different methods of screening blood donations for HBsAg.
    Barbara JA; Howell DR; Cleghorn TE; Cameron CH; Briggs M; Dane DS
    Vox Sang; 1977; 32(1):4-9. PubMed ID: 841961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatitis B antigen in blood donors by radioimmunoassay and three reverse passive haemagglutination techniques.
    Seidl S; Ziegler GB
    Vox Sang; 1976; 31(2):81-86. PubMed ID: 951976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of three reverse passive haemagglutination methods and two radioimmunoassay tests to be used for the detection of hepatitis B surface antigen.
    Hansson BG
    Acta Pathol Microbiol Scand C; 1976 Feb; 84(1):53-8. PubMed ID: 1266626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HBsAg in blood donors. A comparative study using radioimmunoassay, enzymeimmunoassay, reverse passive haemagglutination and latex tests.
    Seidl S; Trautmann L
    Rev Fr Transfus Immunohematol; 1981 Jun; 24(3):319-35. PubMed ID: 7025162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sandwich enzymoimmunoassay of hepatitis B surface antigen (HBsAg).
    Adachi H; Fukuda T; Funahashi S; Kurahori T; Ishikawa E
    Vox Sang; 1978; 35(4):219-23. PubMed ID: 358585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of micro enzyme immunoassay technique (MEIA) for the demonstration of hepatitis B surface antigen].
    Kashiwagi S; Hayashi J; Noguchi A; Nakashima K; Hirata M
    Kansenshogaku Zasshi; 1991 Feb; 65(2):185-92. PubMed ID: 2066601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new reversed passive hemagglutination test for detection of HBsAg.
    Prince AM; Ikram H; Chicot D; Wright R; Vnek J; Neurath R; Lippin A; Swiss S
    Vox Sang; 1975; 29(5):319-29. PubMed ID: 1105975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive single reverse passive haemagglutination test for detecting both HBsAg and anti-HBs.
    Barbara JA; Harrison PJ; Howell DR; Cleghorn TE; Dane DS; Briggs M; Cameron CH
    J Clin Pathol; 1979 Nov; 32(11):1180-3. PubMed ID: 512031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for the automated screening for hepatitis B surface antigen.
    Kunitomo K; Saji H; Yahara S; Hosoi T
    Vox Sang; 1980 Oct; 39(4):215-21. PubMed ID: 7210611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of HBsAg in screening donors].
    Wang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Dec; 10(6):363-5. PubMed ID: 2624939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of three technics of inverse passive hemagglutination in the search for a surface antigen of the hepatitis b virus (Ag HBs) (author's transl)].
    Chevallier P; Trepo D; Trepo C; Sepetijian M
    Pathol Biol (Paris); 1977 May; 25(5):341-4. PubMed ID: 327414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to confirm specificity of samples containing a very high titer of hepatitis B surface antigen (HBsAg).
    Nath N; Armbruster A; Ellis FR
    Transfusion; 1979; 19(3):321-3. PubMed ID: 452071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies of the distribution of hepatitis B markers among blood donors and patients with post-transfusion hepatitis in the city of Sofia].
    Gubev E; Rashkov R; Dimitrova T; Sharankov N; Andonov A
    Vutr Boles; 1987; 26(3):38-43. PubMed ID: 3617705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A retrospective study of HBsAG carriers in the blood bank of Navarra].
    Medarde A; del Hierro J; Aramburu E; Esquíroz P; Martínez JL
    Rev Med Univ Navarra; 1988; 32(4):209-16. PubMed ID: 3155332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of screening blood donors for antibody to hepatitis B core antigen.
    Archer AC; Cohen BJ; Mortimer PP
    J Clin Pathol; 1983 Aug; 36(8):924-8. PubMed ID: 6875019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of potential risk of HBsAg negative with RPHA].
    Xiao YJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1991 May; 25(3):158-60. PubMed ID: 1914681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of serum myoglobin by the reverse passive hemagglutination assay (RPHA) and radioimmunoassay (RIA).
    Radu I; Zaharescu J; Mateescu M; Mihalache D
    Roum Arch Microbiol Immunol; 1993; 52(4):285-92. PubMed ID: 7827365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.